Kaitlin A. Read

Kaitlin A. Read studies how immune cells, particularly CD4+ T cells, are controlled by internal regulatory proteins such as the Ikaros family transcription factors Aiolos and Eos, which influence whether these cells become inflammatory, memory-forming, or cell-killing types. Her work also extends into engineering T cells for cancer therapy, including improving CAR T cell (genetically modified immune cells used to attack tumors) function and persistence. This research aims to better understand and manipulate immune cell decision-making for applications in autoimmune disease, infection, and cancer immunotherapy.

Publication output has fluctuated over the past decade, peaking in 2019, dipping in 2020-2021, and maintaining a moderate, fairly steady pace of about 5-7 papers per year since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026